tirzepatide dual action is a groundbreaking, once-weekly injectable medication that acts as a GIP and GLP-1 receptor agonist. Marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, it mimics 1 and GIP mechanism in a daily Compounded Tirzepatide — Dual GLP-1/GIP
Pay in 4 interest-free payments of $7.11 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3








:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)









.png)
![Omekamon [BT20-083] Rare Alt Art BOX](https://cdn.shopify.com/s/files/1/0617/4549/6150/files/BT20-083_P4.png?v=1774503924)



